Ardentis
Advancing Better Health
Ardentis Pharma Logo
LORVEXA
Medicine Information
This product is a pharmaceutical. Information on use, preparation, and administration should only be considered in accordance with the package insert and the instructions of a healthcare professional.
Injectable Medicines 8 mg

LORVEXA

Active ingredient: Lornoxicam 8 mg. Excipients: Mannitol 100 mg, Tromethamine 12.0 mg, Edetate Disodium 0.2 mg. Solvent: Sterile Water for Injection 5 mL.

Lornoxicam lyophilized powder for injection with solvent, 8 mg, 1 vial + 1 ampoule. Lyophilized powder for injection with solvent.

Product Features

  • Lornoxicam 8 mg
  • 1 vial + 1 ampoule per box
  • I.M. / I.V. as labeled
  • Protect from light

Usage Information

Administration: I.M. / I.V. For dosage and administration, read the enclosed leaflet. Protect from light and store in an airtight container at a temperature not exceeding 25°C. Keep the vial in the outer carton to protect from light.

Ingredients

Active ingredient: Lornoxicam 8 mg. Excipients: Mannitol 100 mg, Tromethamine 12.0 mg, Edetate Disodium 0.2 mg. Solvent: Sterile Water for Injection 5 mL.

Warning
Important Warning: This product is a medicine. It must not be used without medical advice. Dose, route of administration and treatment duration must be determined by a healthcare professional.